Cyclo Therapeutics Stock Buy Hold or Sell Recommendation
| CYTHW Stock | USD 0.14 0.04 22.22% |
Assuming the 90 days horizon and your complete indifference towards market risk, our recommendation regarding Cyclo Therapeutics is 'Hold'. A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Cyclo Therapeutics given historical horizon and risk tolerance towards Cyclo Therapeutics. When Macroaxis issues a 'buy' or 'sell' recommendation for Cyclo Therapeutics, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out Cyclo Therapeutics Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For more information on how to buy Cyclo Stock please use our How to Invest in Cyclo Therapeutics guide. Note, we conduct extensive research on individual companies such as Cyclo and provide practical buy, sell, or hold advice based on investors' constraints. Cyclo Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.
Cyclo |
Execute Cyclo Therapeutics Buy or Sell Advice
The Cyclo recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Cyclo Therapeutics. Macroaxis does not own or have any residual interests in Cyclo Therapeutics or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Cyclo Therapeutics' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Hold
Market Performance | OK | Details | |
Volatility | Out of control | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Moves completely opposite to the market | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Not Available | Details | |
Financial Strenth (F Score) | Frail | Details | |
Financial Leverage | Inapplicable | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Cyclo Therapeutics Trading Alerts and Improvement Suggestions
| Cyclo Therapeutics is way too risky over 90 days horizon | |
| Cyclo Therapeutics has some characteristics of a very speculative penny stock | |
| Cyclo Therapeutics appears to be risky and price may revert if volatility continues | |
| Cyclo Therapeutics has accumulated 1.03 M in total debt. Cyclo Therapeutics has a current ratio of 0.85, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Note, when we think about Cyclo Therapeutics' use of debt, we should always consider it together with its cash and equity. | |
| The entity reported the revenue of 1.08 M. Net Loss for the year was (20.06 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Cyclo Therapeutics has accumulated about 2.24 M in cash with (16.19 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.32, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Cyclo Therapeutics has a frail financial position based on the latest SEC disclosures | |
| Latest headline from news.google.com: Cyclo Therapeutics, Inc. Reports Q3 Loss, Lags Revenue Estimates - MSN |
Cyclo Therapeutics Returns Distribution Density
The distribution of Cyclo Therapeutics' historical returns is an attempt to chart the uncertainty of Cyclo Therapeutics' future price movements. The chart of the probability distribution of Cyclo Therapeutics daily returns describes the distribution of returns around its average expected value. We use Cyclo Therapeutics price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Cyclo Therapeutics returns is essential to provide solid investment advice for Cyclo Therapeutics.
| Mean Return | 1.58 | Value At Risk | -33.33 | Potential Upside | 46.07 | Standard Deviation | 20.53 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Cyclo Therapeutics historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Cyclo Therapeutics Cash Flow Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change To Inventory | 160.6K | 4.7K | 10.5K | (27.1K) | (52.8K) | (50.1K) | |
| Change In Cash | 566.3K | 10.1M | 3.8M | (15.1M) | 7.7M | 8.1M | |
| Free Cash Flow | (6.6M) | (8.6M) | (15.0M) | (15.1M) | (16.2M) | (15.4M) | |
| Depreciation | 5.7K | 12.8K | 16.8K | 19.5K | 19.3K | 18.3K | |
| Other Non Cash Items | 13.3K | 74.7K | 21.9K | (148.3K) | 52.9K | 61.1K | |
| Capital Expenditures | 1.3K | 53.1K | 22.5K | 15.1K | 2.4K | 2.3K | |
| Net Income | (7.5M) | (8.9M) | (14.3M) | (15.5M) | (20.1M) | (19.1M) | |
| End Period Cash Flow | 2.8M | 12.8M | 16.6M | 1.5M | 9.2M | 9.7M | |
| Investments | 36.1K | (14.0K) | 14.8K | 53.3K | (2.4K) | (2.3K) |
Cyclo Therapeutics Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Cyclo Therapeutics or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Cyclo Therapeutics' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Cyclo stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 1.78 | |
β | Beta against Dow Jones | -2.16 | |
σ | Overall volatility | 20.54 | |
Ir | Information ratio | 0.07 |
Cyclo Therapeutics Volatility Alert
Cyclo Therapeutics is showing large volatility of returns over the selected time horizon. Cyclo Therapeutics is a potential penny stock. Although Cyclo Therapeutics may be in fact a good instrument to invest, many penny stocks are speculative in nature and are subject to artificial price hype. Please make sure you totally understand the upside potential and downside risk of investing in Cyclo Therapeutics. We encourage investors to look for signals such as email spams, message board hypes, claims of breakthroughs, volume upswings, sudden news releases, promotions that are not reported, or demotions released before SEC filings. Please also check biographies and work history of current and past company officers before investing in high volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on Cyclo instrument if you perfectly time your entry and exit. However, remember that penny stocks that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.Cyclo Therapeutics Fundamentals Vs Peers
Comparing Cyclo Therapeutics' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Cyclo Therapeutics' direct or indirect competition across all of the common fundamentals between Cyclo Therapeutics and the related equities. This way, we can detect undervalued stocks with similar characteristics as Cyclo Therapeutics or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Cyclo Therapeutics' fundamental indicators could also be used in its relative valuation, which is a method of valuing Cyclo Therapeutics by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Cyclo Therapeutics to competition |
| Fundamentals | Cyclo Therapeutics | Peer Average |
| Return On Equity | -226.64 | -0.31 |
| Return On Asset | -2.82 | -0.14 |
| Operating Margin | (45.78) % | (5.51) % |
| Number Of Shares Shorted | 100 | 4.71 M |
| Revenue | 1.08 M | 9.43 B |
| EBITDA | (20.03 M) | 3.9 B |
| Net Income | (20.06 M) | 570.98 M |
| Cash And Equivalents | 2.24 M | 2.7 B |
| Cash Per Share | 1.32 X | 5.01 X |
| Total Debt | 1.03 M | 5.32 B |
| Current Ratio | 0.87 X | 2.16 X |
| Book Value Per Share | 0.17 X | 1.93 K |
| Cash Flow From Operations | (16.19 M) | 971.22 M |
| Number Of Employees | 8 | 18.84 K |
| Beta | -0.38 | -0.15 |
| Market Capitalization | 62.76 M | 19.03 B |
| Total Asset | 13.25 M | 29.47 B |
| Retained Earnings | (83.86 M) | 9.33 B |
| Working Capital | 3.85 M | 1.48 B |
| Net Asset | 13.25 M |
Note: Acquisition by Toig Randall M. of 3350 shares of Cyclo Therapeutics at 1.28 subject to Rule 16b-3 [view details]
Cyclo Therapeutics Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Cyclo . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Daily Balance Of Power | (9,223,372,036,855) | |||
| Rate Of Daily Change | 0.78 | |||
| Day Median Price | 0.14 | |||
| Day Typical Price | 0.14 | |||
| Price Action Indicator | (0.02) | |||
| Period Momentum Indicator | (0.04) | |||
| Relative Strength Index | 47.08 |
About Cyclo Therapeutics Buy or Sell Advice
When is the right time to buy or sell Cyclo Therapeutics? Buying financial instruments such as Cyclo Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Cyclo Therapeutics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Energy Funds Thematic Idea Now
Energy Funds
Funds or Etfs investing in energy sector, natural resources, and ecology. The Energy Funds theme has 41 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Energy Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Cyclo Stock Analysis
When running Cyclo Therapeutics' price analysis, check to measure Cyclo Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cyclo Therapeutics is operating at the current time. Most of Cyclo Therapeutics' value examination focuses on studying past and present price action to predict the probability of Cyclo Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cyclo Therapeutics' price. Additionally, you may evaluate how the addition of Cyclo Therapeutics to your portfolios can decrease your overall portfolio volatility.